Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors

Immune checkpoint inhibitors (ICI), which target immune regulatory pathways to unleash antitumor responses, have revolutionized cancer immunotherapy. Despite the remarkable success of ICI immunotherapy, a significant proportion of patients whose tumors respond to these treatments develop immune-rela...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Immunol Res
Prif Awduron: Grigoriou, Maria, Banos, Aggelos, Hatzioannou, Aikaterini, Kloetgen, Andreas, Kouzis, Panagiotis, Aggouraki, Despoina, Zakopoulou, Roubini, Bamias, Giorgos, Kassi, Eva, Mavroudis, Dimitrios, Bamias, Aristotelis, Boumpas, Dimitrios T., Tsirigos, Aristotelis, Gogas, Helen, Alissafi, Themis, Verginis, Panayotis
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611354/
https://ncbi.nlm.nih.gov/pubmed/33820810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-20-0969
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg